Heron Therapeutics (HRTX) Cash & Equivalents Growth (3y) (2013 - 2026)
Heron Therapeutics (HRTX) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
24.73% |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-40.88% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
-28.55% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
21.66% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
-16.07% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Heron Therapeutics |
77.43 Mn |
47.47 Mn |
24.07 Mn |
78.11% |
| Date | Value |
|---|
| Mar 31, 2026 |
78.11% |
| Dec 31, 2025 |
97.75% |
| Sep 30, 2025 |
-30.54% |
| Jun 30, 2025 |
56.61% |
| Mar 31, 2025 |
-40.56% |
| Dec 31, 2024 |
-72.42% |
| Sep 30, 2024 |
-58.39% |
| Jun 30, 2024 |
-54.18% |
| Mar 31, 2024 |
-55.68% |
| Dec 31, 2023 |
-63.06% |
| Sep 30, 2023 |
70.77% |
| Jun 30, 2023 |
20.99% |
| Mar 31, 2023 |
-73.15% |
| Dec 31, 2022 |
-72.47% |
| Sep 30, 2022 |
62.29% |
| Jun 30, 2022 |
-56.72% |
| Mar 31, 2022 |
-5.18% |
| Dec 31, 2021 |
115.08% |
| Sep 30, 2021 |
113.49% |
| Jun 30, 2021 |
-9.62% |
